Vertex Pharma: Spanish Government Approves Terms For Reimbursement Of KAFTRIO

Vertex Pharmaceuticals Incorporated (VRTX) announced the government in Spain has approved terms for the national reimbursement of KAFTRIO in a combination regimen with ivacaftor for the treatment of cystic fibrosis. The company noted that, with this agreement, Spain joins the group of over 25 countries, where eligible patients with cystic fibrosis have access to the triple combination therapy.

The agreement covers people with cystic fibrosis ages 12 years and older who have at least one copy of the F508del mutation, regardless of the other mutation type in the CFTR gene.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The US Centers for Disease Control and Prevention or CDC has ended recommendations for social distancing and quarantine with a view to minimize covid-19's impact on persons, communities, and health care systems. The agency also ended recommendation for test-to-stay in schools, CNN noted. Healthcare major Johnson & Johnson, which is in the middle of a talcum powder fiasco, said it is discontinuing talc-based JOHNSON'S Baby Powder globally in 2023. The company plans to transition to an all cornstarch-based baby powder portfolio. According to the company, the commercial decision to use cornstarch in all its baby powder products was made after conducting an assessment of its portfolio Walt Disney's streaming service Disney+ is rolling out its much-anticipated new ad-supported subscription plan for Disney+ in the U.S. as part of its bid to stem the loss and make its streaming business profitable after the services posted a hefty operating loss of more than $1 billion in the third quarter. It is also raising pricing for its bundled subscription plans with Hulu, ESPN+ and live TV.
Follow RTT